XSHE
300401
Market cap1.34bUSD
Feb 24, Last price
16.90CNY
1Q
23.63%
Jan 2017
11.27%
IPO
661.26%
Name
Zhejiang Garden Biopharmaceutical Co Ltd
Chart & Performance
P/E
29.70
P/S
7.39
EPS
0.57
Div Yield, %
0.67%
Shrs. gr., 5y
4.49%
Rev. gr., 5y
11.59%
Revenues
1.24b
+13.58%
Net income
309m
+60.76%
CFO
466m
+191.53%
Dividend
Apr 30, 20250.114 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zhejiang Garden Bio-chemical High-tech Co., Ltd., together with its subsidiaries, manufactures and supplies vitamin D3, cholesterol, and calcifediol in China. Its products have applications in food additives, nutrition and health products, and medicine. The company was founded in 2000 and is based in Dongyang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||